Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Feb 20;28(5):926–934. doi: 10.1158/1055-9965.EPI-18-0917

Table 1:

Patient factors associated with genetic testing (univariate analysis).

Had genetic test No genetic test
N (%) N (%) P-value
SES Variables
Income <.0001 *
Low income 319 (7.8) 3893 (92.4)
Not low income 721 (12.7) 4967 (87.3)
High-poverty location <.0001 *
High-poverty 439 (8.3) 4870 (91.7)
Not high-poverty 554 (13.2) 3648 (86.8)
Demographic and Clinical Characteristics
Sex <.0001 *
Female 590 (11.8) 4432 (88.2)
Male 450 (9.2) 4428 (90.8)
Race <.0001 *
White 859 (10.8) 7095 (89.2)
Black 53 (5.3) 953 (94.7)
Asian 74 (14.8) 425 (85.2)
Hispanic 15 (7.7) 181 (92.3)
Other or unknown 39 (15.9) 206 (84.1)
Histology <.0001 *
Adenocarcinoma 787 (15.3) 4345 (84.7)
Other non-small cell 253 (5.3) 4515 (94.7)
Age at diagnosis 0.0038 *
Under 75 531 (11.5) 4104 (88.5)
75 or older 509 (9.7) 4756 (90.3)
Urban location <.0001 *
Urban 908 (11.0) 7345 (89.0)
Not urban 86 (6.7) 1208 (93.3)
Diagnosis year <.0001 *
2007 31 (1.6) 1900 (98.4)
2008 61 (3.2) 1867 (96.8)
2009 182 (9.1) 1810 (90.9)
2010 316 (15.5) 1727 (84.5)
2011 450 (22.4) 1556 (77.6)
Charlson index <.0001 *
0 438 (14.4) 2596 (85.6)
1 283 (9.6) 2671 (90.4)
2 141 (8.7) 1477 (91.3)
3+ 165 (8.0) 1909 (92.0)
*

= Significant at the 0.05 level